期刊
INTERNATIONAL JOURNAL OF HEMATOLOGY
卷 92, 期 1, 页码 105-110出版社
SPRINGER JAPAN KK
DOI: 10.1007/s12185-010-0613-x
关键词
B-lineage acute lymphoblastic leukemia; Midkine; Multiple drug resistance; Drug efflux
类别
资金
- Natural Science Key Program of Science and Technology Commission Foundation of Tianjin of China [08JCZDJC19100, 09JCZDJC17300]
- Ph.D. Programs Foundation of Ministry of Education of China [20091106110038]
Multidrug resistance (MDR) induced by drug efflux has been identified as the major clinical obstacle in the treatment of childhood acute lymphoblastic leukemia (ALL). To explore the possible effects of midkine (MK) gene on the chemotherapeutic drugs efflux, we examined the MK gene expression in 139 B-lineage ALL patients and 15 children with nonmalignant hematological diseases. Meanwhile, we detected the degree of drug accumulation in 30 progressing B-lineage ALL patients and the 15 control individuals (as control). The results showed that the significant statistic difference in MK gene expression was found among the normal group, the complete remission (CR), and progressing B-lineage ALL patients (p < 0.01). In the Rhodamine 123 (Rh123) efflux test, mean fluorescence intensity (MFI) in the leukemia cells was obviously lower than that in normal pre-B cells (p < 0.01). Furthermore, there was an evident negative correlation between the MFI and MK mRNA expression (r = -0.869, p < 0.001) but no correlation with the MDR1 mRNA expression (p > 0.05). We concluded that there was powerful drug efflux ability in lymphoblastic leukemia cells with high MK gene expression. MK gene may take part in multidrug resistance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据